Clinical Trial Update: Stellate Ganglion Block as Adjuvant Therapy to ca Channel Blocker [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating stellate ganglion block as adjuvant therapy to a calcium channel blocker for subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• Calcium channel blocker (calcium channel blocker)
• Stellate Ganglion Block

Snippet

Sponsor: Assiut University | Conditions: Subarachnoid Hemorrhage | Phase 2 | Status: COMPLETED